FDA updates remote monitoring guidance, approves generic intubation drugs

by on

FDA updates remote monitoring guidance, approves generic intubation drugs
tjordan_drupal
Oct 29, 2020

The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.

FDA said the document expands on devices, including gaseous-phase carbon-dioxide gas analyzers, which include capnographs and devices with capnography features.

FDA yesterday also approved two generic injectable drugs to facilitate tracheal intubation: succinylcholine chloride and cisatracurium besylate. These drugs are intended to help meet the demand for skeletal muscle relaxation during surgery or mechanical ventilation during the COVID-19 emergency.

Headline

FDA updates remote monitoring guidance, approves generic intubation drugs
tjordan_drupal
Oct 29, 2020

The Food and Drug Administration Wednesday updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.

FDA said the document expands on devices, including gaseous-phase carbon-dioxide gas analyzers, which include capnographs and devices with capnography features.

FDA yesterday also approved two generic injectable drugs to facilitate tracheal intubation: succinylcholine chloride and cisatracurium besylate. These drugs are intended to help meet the demand for skeletal muscle relaxation during surgery or mechanical ventilation during the COVID-19 emergency.

Novel Coronavirus (COVID-19)
COVID-19: CDC, FDA and CMS Guidance

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: